Please provide your email address to receive an email when new articles are posted on . Plasma phosphorylated tau at threonine 181 served as “an accessible and scalable marker” of neurodegeneration ...

In psychopathology, the p-factor suggests the presence of a common factor driving various mental health disorders. A recent Translational Psychiatry study aimed to discover p-factor-related plasma ...

How early in the course of Alzheimer’s disease can a blood marker detect amyloid pathology, and which marker does it best? At this year’s Alzheimer’s Association International Conference, held from ...

The D-dimer test is often used to rule out the presence of venous thromboembolism; however, the test has been considered unreliable in postoperative patients because D-dimer levels may rise after ...

Plasma NfL, GFAP up in severe COVID, normalized by six months. Serum Aβ42 lower, tau higher in cases with neurological symptoms. Six months post-COVID, half of all survivors still had a cognitive ...

Department of Medical Chemistry and Biochemistry, University of Innsbruck Medical School, Austria. OBJECTIVE: To test whether fatty acid binding protein (FABP) is a useful plasma marker for the early ...

CHICAGO (July 25, 2008) – New research published in the July issue of the Journal of the American College of Surgeons shows elevated plasma DNA is a reliable marker of recurrent esophageal cancer. The ...

Background: The changes in the liver in nonalcoholic fatty liver disease (NAFLD) range over a wide spectrum, extending from steatosis to steatohepatitis (NASH). However it has remained difficult to ...

Organ-function preservation in advanced oropharynx cancer: results with induction chemotherapy and radiation. CgA levels increased in 59 of 60 patients (245% +/- 18% increase above baseline levels, P ...

Plasma circulating tumor DNA (ctDNA) analysis is routine for genotyping of advanced non–small-cell lung cancer (NSCLC); however, early response assessment using plasma ctDNA has yet to be well ...